ЭПИДЕМИОЛОГИЯ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ
https://doi.org/10.24884/1561-6274-2010-14-1-50-55
Аннотация
Имеющиеся данные свидетельствуют, что распространенность хронической болезни почек (ХБП) среди больных с хронической сердечной недостаточностью (ХСН) составляет от 9,2 при ХСН, обусловленной врожденными пороками сердца, до 71,2% – при ХСН, обусловленной ишемической болезнью сердца (ИБС) и артериальной гипертонией. Снижение функции почек ассоциировано с возрастом и функциональным классом ХСН. Однако, если низкую частоту ХБП среди больных с ХСН с врожденными пороками сердца можно объяснить молодым возрастом и нетяжелой ХСН, то причины значительного различия в распространенности ХБП у больных с ХСН, обусловленной ИБС и артериальной гипертонией, остаются неясными. Требует уточнения распространенность ХБП как среди больных с ХСН в целом, так и в отдельных группах больных. Необходимо уточнение причины гендерных особенностей ХСН, ассоциированной с ХБП. Целесообразно проведение не только клинических, но и клинико-экономических исследований, при этом следует учитывать, что результаты, полученные зарубежными исследователями, нельзя безоговорочно использовать в России, так как имеются значительные отличия как в организации медицинской помощи населению, так и в спектре медикаментозных препаратов, особенно препаратов-дженериков, используемых при лечении ХСН.
Об авторах
В. А. Серов
Ульяновский государственный университет
Россия
Россия
кафедра терапии и профессиональных болезней медицинского факультета
432072, г. Ульяновск, ул. 40-летия Победы, д. 14, кв. 62. Тел.: (8422) 55-27-08
А. М. Шутов
Ульяновский государственный университет
Россия
Россия
кафедра терапии и профессиональных болезней медицинского факультета
М. В. Мензоров
Ульяновский государственный университет
Россия
Россия
кафедра терапии и профессиональных болезней медицинского факультета
Е. Р. Макеева
Ульяновский государственный университет
Россия
Россия
кафедра терапии и профессиональных болезней медицинского факультета
Д. В. Серова
Ульяновский государственный университет
Россия
Россия
кафедра терапии и профессиональных болезней медицинского факультета
Список литературы
1. Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115 (5): e 69–171
2. Neumann T, Biermann J, Erbel R et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009; 106 (16): 269–275
3. Фомин ИВ, Беленков ЮН, Мареев ВЮ. Распространенность ХСН в Европейской части Российской федерации – данные ЭПОХА-ХСН. Сердечная недостаточность 2006; 7 (1): 4–7
4. Rodrнguez-Artalejo F, Banegas Banegas JR, Guallar-Castillуn P. Epidemiology of heart failure. Rev Esp Cardiol 2004; 57 (2): 163-170
5. Pocock SJ, Wang D, Pfeffer MA et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27 (1): 65–75
6. Henkel DM, Redfield MM, Weston SA et al. Death in heart failure: a community perspective. Circ Heart Fail 2008; 1 (2): 91–97
7. Chae CU, Albert CM, Glynn RJ et al. Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. Am J Cardiol 2003; 92 (6): 682–686
8. Fаcila L, Bertomeu V, Bertomeu-Gonzаlez V et al. Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) 2009; 11 (6): 303–308
9. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112; e154–e235
10. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 2007; 23 (1): 21–45
11. Национальные Рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2007; 1: 4–41
12. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed incollaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 2008; 29 (19): 2388–2442
13. Amsalem Y, Garty M, Schwartz R et al. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J 2008; 29 (8): 1029–1036
14. Dimopoulos K, Diller GP, Koltsida E et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008; 117 (18): 2320–2328
15. Hillege HL, Nisch D, Pfeffer MA et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671–678
16. Ghali JK, Wikstrand J, Van Veldhuisen DJ et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). J Card Fail 2009; 15 (4): 310–318
17. Ezekowitz J, McAlister FA, Humphries KH et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004; 44 (8): 1587–1592
18. Go AS, Yang J, Ackerson LM et al. Hemoglobin lel, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113 (23): 2713–2723
19. Ahmed A, Rich MW, Sanders PW et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007; 99 (3): 393–398
20. Shiba N, Matsuki M, Takahashi J et al. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J 2008; 72 (2): 173–178
21. de Silva R, Nikitin NP, Witte KK et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006; 27 (5): 569–581
22. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109 (8): 1004–1009
23. Zamora E, Lupуn J, Urrutia A et al. Prognostic significance of creatinine clearance rate in patients with heart failure and normal serum creatinine. Rev Esp Cardiol 2007; 60 (12): 1315–1318
24. Patel UD, Hernandez AF, Liang L et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines – Heart Failure Program study. Am Heart J 2008; 156 (4): 674–681
25. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S et al. Chronic Kidney Disease as an Independent Risk for Long-Term Adverse Outcomes in Patients Hospitalized With Heart Failure in Japan. Circ J 2009; 73 (8): 1442–1447
26. Smith GL, Shlipak MG, Havranek EP et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005; 111 (10): 1270–1277
27. Трошенькина ОВ, Серов ВА, Шутов АМ и соавт. Распространенность хронической болезни почек у больных с хронической сердечной недостаточностью. Актуальные проблемы медицинской науки и образования. Сборник трудов II межрегиональной научной конференции. ИИЦ ПГУ Пенза, 2009; 245–246
28. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130 (6): 461–470
29. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53 (6): 982–992
30. Zhao WY, Zeng L, Zhu YH et al. A comparison of prediction equations for estimating glomerular filtration rate in Chinesepotential living kidney donors. Clin Transplant 2009; 23 (4): 469–475
31. Шабалин АВ. Гериатрическая кардиология. Диагностика и лечение хронической сердечной недостаточности у больных пожилого возраста. В: Оганов Р.Г., Фомина И.Г. Болезни сердца. Руководство для врачей. Литтерра, М., 2006; 1225–1242
32. Spiecker M. Heart failure in elderly patients. Exp Gerontol 2006; 41 (5): 549–551
33. Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci2007; 1100: 353-360
34. Franzoni F, Ghiadoni L, Galetta F et al. Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens 2005; 18 (4 Pt 1): 510–516
35. Oxenham H, Sharpe N. Cardiovascular aging and heart failure.Eur J Heart Fail 2003; 5 (4): 427-434
36. Bursi F, Weston SA, Redfield MM et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296 (18): 2209–2216
37. Cheitlin MD. Cardiovascular physiology-changes with aging. Am J Geriatr Cardiol 2003; 12 (1): 9–13
38. O’Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50 (1): 1–13
39. Amann K, Tyralla K. Cardiovascular changes in chronic renal failure–pathogenesis and therapy. Clin Nephrol 2002; 58 Suppl 1: S62–72
40. Guеrin AP, Pannier B, Marchais SJ, London GM. Arterial structure and function in end-stage renal disease. Curr Hypertens Rep 2008; 10 (2): 107–111
41. Zhang L, Zhao F, Yang Y et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis 2007; 49 (6): 786–792
42. Galvao M, Kalman J, DeMarco T et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail 2006; 12 (2): 100–107
43. Rosengren A, Hauptman P. Women, men and heart failure: a review. Heart Fail Monit 2008; 6 (1): 34–40
44. Терещенко СН, Жиров ИВ. Хроническая сердечная недостаточность у женщин. Журнал Сердечная недостаточность 2008; 6: 295–298
45. Lund LH, Mancini D. Heart failure in women. Med Clin North Am 2004; 88 (5): 1321–1345
46. O’Meara E, Clayton T, McEntegart MB et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007; 115 (24): 3111–3120
47. Deswal A, Bozkurt B. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 2006; 97 (8): 1228–1231
48. Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49 (5): 572–577
49. Frazier CG, Alexander KP, Newby LK et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J Am Coll Cardiol 2007; 49 (13): 1450–1458
50. Wiinber N, Hoegholm A, Christensen H et al. 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8: 978–986
51. Mahmoodzadeh S, Eder S, Nordmeyer J et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J 2006; 20 (7): 926–934
52. Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation 2007; 116: 2747–2759
53. Reckelhoff JF, Yanes LL, Iliescu R et al. Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol 2005; 289 (5): F941–948
54. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5 Suppl A: S3–S10
55. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117
56. Nitsch D, Felber Dietrich D, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21 (4): 935–944
57. Grabysa R, Cholewa M. Predictors of chronic kidney disease in hypertensive patients. Pol Merkur Lekarski 2008; 25 (145): 9–14
58. Rogers JL, Mitchell AR, Maric C et al. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol 2007; 292: R794–R799
59. Kienitz T, Quinkler M. Testosterone and blood pressure regulation. Kidney Blood Press Res 2008; 31 (2): 71–79
60. Yanes LL, Sartori-Valinotti JC, Iliescu R et al. Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol 2009; 296 (4): F771–F779
61. Gandolfo MT, Verzola D, Salvatore F et al. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 2004; 56 (1): 1–14
62. Kang DH, Yu ES, Yoon KI, Johnson R. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 2004; 164 (2): 679–688
63. Regitz-Zagrosek V, Lehmkuhl E, Lehmkuhl HB. Herzinsuffizienz – geschlechtsspezifische Aspekte? Internist (Berl) 2008; 49 (4): 422–428
64. Gross ML, Ritz E, Korsch M et al. Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats. Kidney Int 2005; 67 (3): 849–857
65. Maric C, Sullivan S. Estrogens and the diabetic kidney. Gend Med 2008; 5 Suppl A: S103–113
66. Silverberg DS, Wexler D, Iaina A et al. Anemia, chronic renal disease and congestive heart failure – the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006; 38 (2): 295–310
Рецензия
Для цитирования:
Серов В.А., Шутов А.М., Мензоров М.В., Макеева Е.Р., Серова Д.В. ЭПИДЕМИОЛОГИЯ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ. Нефрология. 2010;14(1):50-55. https://doi.org/10.24884/1561-6274-2010-14-1-50-55
For citation:
Serov V.A., Shutov A.M., Menzorov M.V., Makeeva E.R., Serova D.V. EPIDEMIOLOGY OF CHRONIC KIDNEY DISEASE PATIENTS WITH CHRONIC HEART FAILURE. Nephrology (Saint-Petersburg). 2010;14(1):50-55. (In Russ.) https://doi.org/10.24884/1561-6274-2010-14-1-50-55
Просмотров:
641
Послать статью по эл. почте 